These universities were placed in the top ten positions of clinical, pre-clinical and health subject ranking by Times Higher Education 2018:
1. University of Oxford, United Kingdom
=2. University of Cambridge, United Kingdom
=2. Harvard University, United States
=4. Imperial College London, United Kingdom
=4. Stanford University, United States
6. Johns Hopkins University, United States
7. University of California, Berkeley, United States
8. Columbia University, United States
9. University of Melbourne, Australia
10. University of Pennsylvania, United States
The discipline-specific tables for clinical, pre-clinical and health studies, released on November 8, follow on from the announcement that Oxford has been ranked the top university in the world by the same publication for the second year running.
The Times Higher Education ranking is based on criteria measuring teaching, research, industry income, international outlook and citations, which are combined to provide a comparison of universities worldwide.
According to a statement released by Oxford, there are around 5,000 full-time equivalent researchers, teachers and staff across the Medical Sciences Division at Oxford, as well as 1,500 graduate and 1,500 undergraduate students.
‘Oxford is a special place because of the close relationship between research, teaching and clinical treatments. Medical Sciences at Oxford is world leading, and we will continue to focus on its future development for the benefit of our students and staff, as well as the patients who will continue to benefit from the excellent research which is constantly transforming lives,' said Professor Gavin Screaton, head of the Medical Sciences Division.
Oxford’s medical sciences division is one of the largest biomedical research centres in Europe, carrying out a substantial number of clinical trials to develop new treatments and to improve patient care and safety.
‘Oxford’s world-leading position in clinical, pre-clinical and health subjects is a reflection of the quality of the researchers based here, whose work is directly translated into innovative therapies for patients,’ said Professor Robert MacLaren, who performed the world’s first operation to deliver new DNA to the eye and reverse sight loss that had been caused by x-linked retinitis pigmentosa - a deteriorating genetic condition which brings a slow and irreversible loss of vision, and which is the leading cause of blindness in young people.
Click here for more Education News